Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2011 Jul;141(1):32-4.
doi: 10.1053/j.gastro.2011.05.022. Epub 2011 May 26.

Myc, Max, and Mnt: molecular mechanisms of enhancement of cholangiocarcinogenesis by cholestasis

Ikuo Nakamura, Lewis R Roberts
Editorial

Myc, Max, and Mnt: molecular mechanisms of enhancement of cholangiocarcinogenesis by cholestasis

Ikuo Nakamura et al. Gastroenterology. 2011 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest

The author discloses no conflicts.

Figures

Figure 1
Figure 1
A scheme for the mechanism of the effect of combined cholestasis and DEN in promoting cholangiocarcinogenesis. In this model, cholestasis is induced by an LMBDL. Neoplasia is induced by DEN treatment. Cholestasis decreases the expression of miR-34a resulting in the expression of c-Myc. Increased Lin-28 expression with consequent down-regulation of the c-Myc suppressor let-7a miRNA appears to play a lesser role in activation of c-Myc expression. Liver injury induced by partial bile duct ligation increases the expression of miR-210 via HIF-2α resulting in decreased Mnt expression. The combination of increased c-Myc and down-regulation of Mnt shifts the balance toward c-Myc–Max activation of cyclin D1 expression, activating the cell cycle and leading to progression of cholangiocarcinogenesis.
See this image and copyright information in PMC

Comment on

References

    1. Sirica AE, Zhang Z, Lai GH, et al. A novel “patient-like” model of cholangiocarcinoma progression based on bile duct inoculation of tumorigenic rat cholangiocyte cell lines. Hepatology. 2008;47:1178–1190. - PubMed
    1. Yang H, Li TWH, Peng J, et al. A mouse model of cholestasis-associated cholangiocarcinoma and transcription factors involved in progression. Gastroenterology. 2011;141:378–388. - PMC - PubMed
    1. Eilers M, Eisenman RN. Myc’s broad reach. Genes & development. 2008;22:2755–2766. - PMC - PubMed
    1. Soucek L, Evan GI. The ups and downs of Myc biology. Curr Opin Genet Dev. 2010;20:91–95. - PMC - PubMed
    1. Dang CV. Enigmatic MYC conducts an unfolding systems biology symphony. Genes Cancer. 2010;1:526–531. - PMC - PubMed

MeSH terms